Items Tagged ‘tarceva’

November 8th, 2016

Personalized Lung Cancer Care & Precision Medicine


Targeted and more-individualized treatment for NSCLC becomes a reality. Lung cancers used to be diagnosed solely by a visual microscopic examination of tumor tissue and all patients received the same chemotherapy. Now, doctors are personalizing care by finding the genetic alterations within the cancer that drive its growth and then use medicines that specifically counteract […]

View full entry

Tags: Alcensa, ALK mutation, EGFR, General Lung Cancer, gilotrif, iressa, Lung Cancer, Lung Cancer - Non-Small Cell, Lung Cancer - Small Cell, Necitumumab, News, nsclc

January 21st, 2015

Stereotactic Body Radiation Therapy Improves Survival in Stage IV Non Small Cell Lung Cancer and Represents New Treatment Option


The results of a recent clinical trial published in the Journal of Clinical Oncology in patients with stage IV non small cell lung caner (NSCLC) suggest that combining stereotactic body radiation therapy (SBRT) with Tarceva (erlotinib) chemotherapy significantly improve survival. Lung cancer remains the leading cause of cancer death in the United States and abroad, […]

View full entry

Tags: erlotinib, General Lung Cancer, Lung Cancer, Lung Cancer - Non-Small Cell, News, non-small cell lung cancer, nsclc, radiation, Recurrent Lung Cancer - Non-Small Cell, sbrt, Stages IIIB-IV Lung Cancer - Non-Small Cell, stereotactic body radiation